Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: BioRestorative Therapies Inc., 3 years.
BioRestorative Therapies Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 20, 2026 | Neuropace Inc. | Shares withheld for tax | −1,162 | $14.28 | $16,593 |
| May 15, 2026 | Neuropace Inc. | Grant or award | +16,820 | — | — |
| Jun 20, 2025 | Neuropace Inc. | Grant or award | +51,850 | — | — |
| Mar 12, 2025 | STAAR Surgical Company | Option exercise | +8,153 | — | — |
| Mar 10, 2025 | STAAR Surgical Company | Option exercise | +4,061 | — | — |
| Mar 7, 2025 | STAAR Surgical Company | Option exercise | +2,614 | — | — |
| Mar 7, 2025 | STAAR Surgical Company | Option exercise | +3,075 | — | — |
| Mar 7, 2024 | STAAR Surgical Company | Option exercise | +2,614 | — | — |
| Aug 10, 2023 | STAAR Surgical Company | Option exercise | +5,122 | — | — |
| Aug 10, 2023 | STAAR Surgical Company | Shares withheld for tax | −2,539 | $44.10 | $111,970 |
| Jun 6, 2023 | STAAR Surgical Company | Option exercise | +5,121 | — | — |
| Jun 6, 2023 | STAAR Surgical Company | Shares withheld for tax | −1,987 | $54.79 | $108,868 |
| Mar 10, 2023 | STAAR Surgical Company | Shares withheld for tax | −289 | $56.63 | $16,366 |
| Mar 10, 2023 | STAAR Surgical Company | Option exercise | +12,184 | — | — |
| Mar 7, 2023 | STAAR Surgical Company | Shares withheld for tax | −1,063 | $58.13 | $61,792 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.